AVH 2.37% $2.47 avita medical inc.

Chinese medicine and devices are facing ever tougher scrutiny in...

  1. 208 Posts.
    lightbulb Created with Sketch. 129
    Chinese medicine and devices are facing ever tougher scrutiny in the US the more time that passes many think Chinese imports will be more highly scrutinized of not outright banned, certain bills (laws) are working their way through our extremely slow govt. by the time ReCell has any issues with possible generic kits, which I still highly doubt, it may not be an issue. China is not really loved here as a manufacturer, it is slow, but they are losing their hold on the manufacture of US goods especially in the medical field, including vitamins. just a couple articles I grabbed off Google.

    http://www.americanmanufacturing.org/blog/entry/china-is-quickly-becoming-the-worlds-pharmacy-and-that-comes-with-great-ris

    https://www.theepochtimes.com/china-manufacturing-of-most-us-medicine-and-vitamins-poses-security-threat-researchers-say_2497862.html
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.